Regulation of cholinergic basal forebrain development, connectivity, and function by neurotrophin receptors
Author(s) -
Zoran Boskovic,
Sonja Meier,
Yunpeng Wang,
Michael R. Milne,
Tessa Onraet,
A Tedoldi,
Elizabeth J. Coulson
Publication year - 2019
Publication title -
neuronal signaling
Language(s) - English
Resource type - Journals
ISSN - 2059-6553
DOI - 10.1042/ns20180066
Subject(s) - basal forebrain , neurotrophin , neuroscience , trk receptor , cholinergic neuron , cholinergic , tropomyosin receptor kinase a , low affinity nerve growth factor receptor , nerve growth factor , biology , tropomyosin receptor kinase b , neurodegeneration , neurotrophic factors , receptor , medicine , disease , biochemistry
Cholinergic basal forebrain (cBF) neurons are defined by their expression of the p75 neurotrophin receptor (p75 NTR ) and tropomyosin-related kinase (Trk) neurotrophin receptors in addition to cholinergic markers. It is known that the neurotrophins, particularly nerve growth factor (NGF), mediate cholinergic neuronal development and maintenance. However, the role of neurotrophin signalling in regulating adult cBF function is less clear, although in dementia, trophic signalling is reduced and p75 NTR mediates neurodegeneration of cBF neurons. Here we review the current understanding of how cBF neurons are regulated by neurotrophins which activate p75 NTR and TrkA, B or C to influence the critical role that these neurons play in normal cortical function, particularly higher order cognition. Specifically, we describe the current evidence that neurotrophins regulate the development of basal forebrain neurons and their role in maintaining and modifying mature basal forebrain synaptic and cortical microcircuit connectivity. Understanding the role neurotrophin signalling plays in regulating the precision of cholinergic connectivity will contribute to the understanding of normal cognitive processes and will likely provide additional ideas for designing improved therapies for the treatment of neurological disease in which cholinergic dysfunction has been demonstrated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom